Franopolis
    vs

    Franchise opportunities compared

    Amerisourcebergen Drug vs Kid to Kid

    Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.

    Amerisourcebergen Drug2026 FDDKid to Kid2026 FDD

    Initial investment · Item 7

    Amerisourcebergen Drug

    $5,000 – $12,000

    2026 FDD · Item 7 · PDF p. 29

    Kid to Kid

    $357,515

    2026 FDD · Item 7 · PDF p. 19

    Initial franchise fee · Item 5

    Amerisourcebergen Drug

    Not available

    Kid to Kid

    Not available

    Royalty · Item 6

    Amerisourcebergen Drug

    Not available

    Kid to Kid

    5%

    2026 FDD · Item 6 · PDF p. 14

    Before you compare

    • Both sets of figures come from 2026 FDDs.
    • Only Kid to Kid has reviewed Item 19 figures here.

    Financial commitment

    Estimated initial investment (Item 7)

    Amerisourcebergen Drug

    $5,000 – $12,000
    xisting pharmacy with no GNP Private Label product on your shelves we estimate an investment of — 5000
    2026 FDD · Item 7 · PDF p. 29

    Kid to Kid

    $357,515
    Single unit — TOTAL
    2026 FDD · Item 7 · PDF p. 19
    Standard initial franchise fee (Item 5)

    Amerisourcebergen Drug

    Not available
    No single standard fee identified

    Kid to Kid

    Not available
    No single standard fee identified
    Royalty (Item 6)

    Amerisourcebergen Drug

    Not available
    No reviewed royalty record

    Kid to Kid

    5%
    Royalty gross sales monthly
    2026 FDD · Item 6 · PDF p. 14
    Brand / advertising fund (Item 6)

    Amerisourcebergen Drug

    Not available
    No reviewed brand or advertising fund fee

    Kid to Kid

    0.5%
    Marketing fund gross sales — 0.5%
    2026 FDD · Item 6 · PDF p. 14

    System scale & health

    Total outlets (Item 20)

    Amerisourcebergen Drug

    2,361
    Outlets at end of 2025
    2026 FDD · Item 20 · PDF p. 55

    Kid to Kid

    Not available
    No reviewed outlet counts
    Net outlet change (Item 20)

    Amerisourcebergen Drug

    +2,162
    Calculated: 199 at end of 2023 → 2,361 at end of 2025

    Kid to Kid

    Not available
    Only one year reported
    Outlet exits (Item 20)

    Amerisourcebergen Drug

    Not available
    No complete exit records for a year

    Kid to Kid

    Not available
    No complete exit records for a year
    Franchising since (Item 1)

    Amerisourcebergen Drug

    Not available
    Not in reviewed records

    Kid to Kid

    Not available
    Not in reviewed records
    Franchisor founded (Item 1)

    Amerisourcebergen Drug

    Not available
    Not in reviewed records

    Kid to Kid

    Not available
    Not in reviewed records

    Financial performance (Item 19), by location group

    Amerisourcebergen Drug

    No reviewed Item 19 figures

    Kid to Kid
    Franchised (69 locations) — other measures
    69 stores
    other franchised all disclosed sample size; financial chart glyphs unreadable
    2026 FDD · Item 19 · PDF p. 59
    Franchised (17 locations) — other measures — franchised second quartile
    17 stores
    other franchised second quartile disclosed sample size; financial chart glyphs unreadable
    2026 FDD · Item 19 · PDF p. 60
    Franchised (18 locations) — other measures
    18 stores
    other franchised fourth quartile disclosed sample size; financial chart glyphs unreadable
    2026 FDD · Item 19 · PDF p. 61
    +12 more groups in the full report

    Item 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.

    Amerisourcebergen Drug vs Kid to Kid: common questions

    Which costs less to open, Amerisourcebergen Drug or Kid to Kid?
    Amerisourcebergen Drug: $5,000 – $12,000 (2026 FDD · Item 7 · PDF p. 29); Kid to Kid: $357,515 (2026 FDD · Item 7 · PDF p. 19). These are each franchisor's Item 7 estimated initial investment. The low end of the disclosed estimate is lower for Amerisourcebergen Drug. Estimates are not quotes, and the FDD years may differ.
    Do Amerisourcebergen Drug and Kid to Kid disclose financial performance (Item 19)?
    Amerisourcebergen Drug has no reviewed Item 19 figures on file; Kid to Kid has reviewed Item 19 figures for 15 location groups. Different location groups are not directly comparable, and revenue is not profit.

    Answers restate the reviewed figures above. Not a ranking or recommendation.

    How Franopolis reviews FDD figures

    Keep researching

    Full Amerisourcebergen Drug report

    Every reviewed fee, Item 19 group, outlet table and territory disclosure

    Full Kid to Kid report

    Every reviewed fee, Item 19 group, outlet table and territory disclosure

    Compare Amerisourcebergen Drug with

    Compare Kid to Kid with

    Add a third brand

    Compare up to four side by side

    Explore by brand

    Filter every published report

    FDD glossary

    Plain-language meaning of each Item